COMMUNIQUÉS West-GlobeNewswire

Avadel Pharmaceuticals Reports Third Quarter 2017 Results
08/11/2017
Total Revenues for the Third Quarter Were $39.7 Million Full Year Revenue Guidance of $165-$175 Million Unchanged Acquired License for Noctiva ™ DUBLIN, Ireland, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals [...]
Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update
08/11/2017
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
G1 Therapeutics Reports Third Quarter 2017 Financial Results and Recent Operational Highlights
08/11/2017
Barclay Phillips appointed Chief Financial Officer and SVP, Corporate Development Management reaffirms expectation of topline data from Phase 2a trial of trilaciclib in first-line small-cell lung cancer in first quarter [...]
Exonics Therapeutics Raises $40 Million in Series A Financing
08/11/2017
CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Exonics Therapeutics, Inc. , a biotechnology company focused on developing SingleCut CRISPR technology to repair mutations causing Duchenne muscular dystrophy and [...]
Fortress Biotech Announces Cellvation’s CEVA101 Granted FDA Regenerative Medicine Advanced Therapy Designation for the Treatment of Traumatic Brain Injury
08/11/2017
Designation to facilitate expedited development and review of CEVA101 for TBI CEVA101 is being developed in partnership with The University of Texas Health Science Center at Houston (UTHealth) NEW YORK, Nov. 08, 2017 ( [...]
Cancer Genetics to Present Insights to Advance Precision Medicine in Non-Small Cell Lung Cancer (NSCLC) at AMP Annual Meeting 2017
08/11/2017
The two presentations at AMP highlight the role of next-generation sequencing in lung cancer biomarker testing, including CGI’s liquid biopsy test, Liquid::Lung -cfDNA™ Thermo Fisher’s next-generation sequencing panels [...]
Nextech Achieves 2015 Edition ONC-Health IT Certification
08/11/2017
TAMPA, Fla., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, today announced achieving the Office of the National Coordinator [...]
Alimera Sciences Announces Nine iluvien® data sets to be Presented at 2017 american academy of ophthalmology
08/11/2017
ATLANTA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that data from [...]
Tyme Provides Clinical and Corporate Update for the Fiscal First Half 2017
08/11/2017
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced an update of its clinical and corporate [...]
Neuralstem Strengthens Executive Leadership Team with Appointment of Dr. David Recker as Chief Medical Officer
08/11/2017
GERMANTOWN, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the appointment of David Recker, [...]
TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2017 Financial Results
08/11/2017
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ) today announced its financial results for the third quarter ended September 30, 2017, and recent company developments. Michael S. Weiss, [...]
Immunovaccine Announces Regulatory Clearance for Phase 2 Clinical Trial Evaluating DPX-Survivac in Combination with Merck’s Checkpoint Inhibitor Pembrolizumab in DLBCL
08/11/2017
HALIFAX, Nova Scotia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage vaccine and immuno-oncology company, today announced that Health Canada has granted Sunnybrook [...]
AroCell AB: Abstract published presenting AroCell TK 210 ELISA from the PROMIX study at the European Society for Medical Oncology Congress in Singapore, November 17-19, 2017
08/11/2017
AroCell AB (publ) announces today that the abstract entitled: "Quantification of cell loss in breast cancer during neoadjuvant treatment (NACT) assessed by serum thymidine kinase protein concentrations (sTK1)", by B [...]
Lundbeck increased operating profit (EBIT) with 126% and EPS by 182% in the first nine months of 2017
08/11/2017
Valby, Denmark, 2017-11-08 07:45 CET (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 12,842 million in the first nine months of 2017 representing an increase of 12% (13% in local currencies) compared to the same [...]
ThromboGenics Strengthens Leadership Team - Susan Schneider, MD appointed Chief Medical Officer and Vinciane Vangeersdaele appointed Chief Commercial Officer
08/11/2017
Press release Leuven, Belgium - 8 November 2017 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for back of the eye diseases and focused on diabetic eye disease, today [...]
Photocure ASA: Results for the third quarter of 2017
08/11/2017
Oslo, Norway, 7 November 2017: Photocure ASA (OSE: PHO ), today reported a revenue growth of 45% for the important US market in the third quarter of 2017, contributing to Hexvix/Cysview revenues of NOK 35.5 million (Q3 [...]
Voyager Therapeutics Announces Pricing of Public Offering of Common Stock
08/11/2017
CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, [...]
VALNEVA Signs $39.6 Million IXIARO® Supply Contract with US Government
08/11/2017
Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on developing innovative, life-saving vaccines, announces today the signing of a $39.6 million one year contract with [...]
Sun BioPharma Announces Execution of Reverse Stock Split
08/11/2017
MINNEAPOLIS, Minn., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, announced [...]

Pages